METEX Stock Overview
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
METabolic EXplorer S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.17 |
| 52 Week High | €1.22 |
| 52 Week Low | €0.13 |
| Beta | 1.16 |
| 1 Month Change | 2.35% |
| 3 Month Change | -54.33% |
| 1 Year Change | -83.58% |
| 3 Year Change | -96.45% |
| 5 Year Change | -90.09% |
| Change since IPO | -98.03% |
Recent News & Updates
METabolic EXplorer S.A. (EPA:METEX) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Feb 10
Why Investors Shouldn't Be Surprised By METabolic EXplorer S.A.'s (EPA:METEX) 27% Share Price Plunge
Dec 18Recent updates
METabolic EXplorer S.A. (EPA:METEX) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Feb 10Why Investors Shouldn't Be Surprised By METabolic EXplorer S.A.'s (EPA:METEX) 27% Share Price Plunge
Dec 18Health Check: How Prudently Does METabolic EXplorer (EPA:METEX) Use Debt?
Oct 01News Flash: One METabolic EXplorer S.A. (EPA:METEX) Analyst Has Been Trimming Their Revenue Forecasts
Jul 30Downgrade: The Latest Revenue And EPS Forecasts For METabolic EXplorer S.A. (EPA:METEX)
Jul 10Does METabolic EXplorer (EPA:METEX) Have A Healthy Balance Sheet?
Jun 14Is METabolic EXplorer S.A. (EPA:METEX) Potentially Undervalued?
May 10What Is METabolic EXplorer S.A.'s (EPA:METEX) Share Price Doing?
Jan 25Statutory Earnings May Not Be The Best Way To Understand METabolic EXplorer's (EPA:METEX) True Position
Oct 06METabolic EXplorer (EPA:METEX) Has Debt But No Earnings; Should You Worry?
May 12The METabolic EXplorer (EPA:METEX) Share Price Has Soared 428%, Delighting Many Shareholders
Mar 18Investors Who Bought METabolic EXplorer (EPA:METEX) Shares A Year Ago Are Now Up 74%
Dec 03
Shareholder Returns
| METEX | FR Chemicals | FR Market | |
|---|---|---|---|
| 7D | -5.4% | -0.4% | -0.4% |
| 1Y | -83.6% | 13.7% | 1.7% |
Return vs Industry: METEX underperformed the French Chemicals industry which returned 15.3% over the past year.
Return vs Market: METEX underperformed the French Market which returned 2.3% over the past year.
Price Volatility
| METEX volatility | |
|---|---|
| METEX Average Weekly Movement | 22.0% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: METEX's share price has been volatile over the past 3 months.
Volatility Over Time: METEX's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 450 | Benjamin Gonzalez | www.metabolic-explorer.com |
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials.
METabolic EXplorer S.A. Fundamentals Summary
| METEX fundamental statistics | |
|---|---|
| Market cap | €8.82m |
| Earnings (TTM) | -€49.34m |
| Revenue (TTM) | €168.17m |
0.1x
P/S Ratio-0.2x
P/E RatioIs METEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| METEX income statement (TTM) | |
|---|---|
| Revenue | €168.17m |
| Cost of Revenue | €174.73m |
| Gross Profit | -€6.56m |
| Other Expenses | €42.78m |
| Earnings | -€49.34m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.97 |
| Gross Margin | -3.90% |
| Net Profit Margin | -29.34% |
| Debt/Equity Ratio | 122.3% |
How did METEX perform over the long term?
See historical performance and comparison